Latest news
Minerva Neurosciences (NASDAQ: NERV) logs $107.9M loss but holds $75.4M cash - Stock TitanStock Titan · Fri, 07 Aug 2026 11:31:14 GMTMinerva Neurosciences: Q2 Earnings Snapshot - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 11:20:14 GMTMinerva Neurosciences Provides Second Quarter 2026 Financial Results and Business Updates - GlobeNewswireGlobeNewswire · Fri, 07 Aug 2026 11:00:00 GMTMinerva's schizophrenia trial is designed to enroll 380 patients - Stock TitanStock Titan · Fri, 07 Aug 2026 11:00:00 GMTMinerva Neurosciences (NERV) awards options tied to Phase 3 trial - Stock TitanStock Titan · Mon, 03 Aug 2026 22:05:46 GMT